Penumbra Debt to Equity Ratio 2014-2022 | PEN

Current and historical debt to equity ratio values for Penumbra (PEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Penumbra debt/equity for the three months ending September 30, 2022 was 0.03.
Penumbra Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-09-30 $0.35B $0.97B 0.36
2022-06-30 $0.36B $0.97B 0.37
2022-03-31 $0.34B $0.96B 0.36
2021-12-31 $0.29B $0.95B 0.30
2021-09-30 $0.29B $0.69B 0.42
2021-06-30 $0.24B $0.67B 0.35
2021-03-31 $0.19B $0.65B 0.29
2020-12-31 $0.19B $0.64B 0.29
2020-09-30 $0.19B $0.62B 0.31
2020-06-30 $0.16B $0.62B 0.25
2020-03-31 $0.18B $0.49B 0.36
2019-12-31 $0.18B $0.49B 0.37
2019-09-30 $0.15B $0.47B 0.32
2019-06-30 $0.13B $0.45B 0.29
2019-03-31 $0.13B $0.44B 0.30
2018-12-31 $0.09B $0.42B 0.22
2018-09-30 $0.09B $0.41B 0.22
2018-06-30 $0.07B $0.43B 0.17
2018-03-31 $0.08B $0.42B 0.18
2017-12-31 $0.08B $0.40B 0.19
2017-09-30 $0.08B $0.38B 0.20
2017-06-30 $0.04B $0.37B 0.12
2017-03-31 $0.05B $0.37B 0.12
2016-12-31 $0.04B $0.27B 0.16
2016-09-30 $0.04B $0.25B 0.17
2016-06-30 $0.04B $0.25B 0.15
2016-03-31 $0.04B $0.24B 0.16
2015-12-31 $0.03B $0.23B 0.14
2015-09-30 $0.03B $0.23B 0.13
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B 0.00
2014-09-30 $0.00B $0.00B 0.00
2013-12-31 $0.02B $0.05B 0.48
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.289B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.442B 23.68
Edwards Lifesciences (EW) United States $48.354B 33.28
Alcon (ALC) Switzerland $36.722B 31.62
STERIS (STE) Ireland $20.456B 25.46
Teleflex (TFX) United States $11.305B 18.34
Fresenius Medical Care AG KGaA (FMS) Germany $10.584B 10.62
Globus Medical (GMED) United States $7.506B 38.16
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.298B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.402B 19.97
Paragon 28 (FNA) United States $1.303B 0.00
Nevro (NVRO) United States $1.291B 0.00
Artivion (AORT) United States $0.505B 0.00